athenaText vs ASCCP Management Guidelines

Collaborate. Consult. Connect. Introducing athenaText, the free, secure text messaging service designed especially for health care providers. Collaborate instantly Exchange information instantly and collaborate easily across care teams. Share texts, images, and medication information with your colleagues. Communicate with security and confidence Because athenaText enables HIPAA-compliant messaging, there's no need to be cryptic to avoid revealing PHI. Communicate clearly and share texts and images with the confidence that your communications are secure. Consult with your peers on the go Tap a network of HCPs across the country, courtesy of Epocrates, the #1 medical app trusted by 1 out of 2 US physicians. Invite HCPs to join you in secure conversations. Add the latest drug information athenaText is also built into athenaOne mobile app as well as athenahealth's desktop services athenaClinicals (EHR) and athenaCoordinator (order transmission & care collaboration). At your clinic or on the go, secure communication is just a tap away.

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.